Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hernández-Breijo, Borja
95  Ergebnisse:
Personensuche X
?
1

Early monitoring of anti-infliximab antibodies by drug-tole..:

Martínez-Feito, Ana ; Novella-Navarro, Marta ; Hernández-Breijo, Borja...
Rheumatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Therapeutic drug monitoring of biopharmaceuticals in inflam..:

Krieckaert, Charlotte ; Hernández-Breijo, Borja ; Gehin, Johanna Elin...
RMD Open.  8 (2022)  2 - p. e002216 , 2022
Link: https://doi.org/10.1136/..
 
?
3

Low Serum BAFF Concentration Is Associated with Response to..:

Hernández-Breijo, Borja ; Parodis, Ioannis ; Novella-Navarro, Marta...
Journal of Clinical Medicine.  11 (2022)  17 - p. 5207 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a ..:

Guijarro, Luis G. ; Cano-Martínez, David ; Toledo-Lobo, M. Val...
Biomedicines.  10 (2022)  3 - p. 727 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Relationship between IGF-1 and body weight in inflammatory ..:

Guijarro, Luis G. ; Cano-Martínez, David ; Toledo-Lobo, M.Val...
Biomedicine & Pharmacotherapy.  144 (2021)  - p. 112239 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Remission Induced by TNF Inhibitors Plus Methotrexate is As..:

Hernández-Breijo, Borja ; Plasencia-Rodríguez, Chamaida ; Navarro-Compán, Victoria...
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
7

Comparison of long-term efficacy between biological agents ..:

Bogas, Patricia ; Plasencia-Rodriguez, Chamaida ; Navarro-Compán, Victoria...
Therapeutic Advances in Musculoskeletal Disease.  13 (2021)  - p. 1759720X2110609 , 2021
Link: https://doi.org/10.1177/..
 
?
8

BAFF predicts immunogenicity in older patients with rheumat..:

Hernández-Breijo, Borja ; Navarro-Compán, Victoria ; Plasencia-Rodríguez, Chamaida...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

Methotrexate Reduces the Probability of Discontinuation of ..:

Hernández-Breijo, Borja ; Brenis, Claudia M. ; Plasencia-Rodríguez, Chamaida...
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
10

Extracellular allograft inflammatory factor-1 (AIF-1) poten..:

Cano-Martínez, David ; Monserrat, Jorge ; Hernández-Breijo, Borja...
Human Immunology.  81 (2020)  2-3 - p. 91-100 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Reduction in antidrug antibody levels after switching to ri..:

Martínez Feito, Ana ; Plasencia-Rodríguez, Chamaida ; Navarro-Compán, Victoria...
Seminars in Arthritis and Rheumatism.  50 (2020)  1 - p. E1-E2 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Dendritic Nanotheranostic for the Delivery of Infliximab: A..:

Rodríguez-Prieto, Tamara ; Hernández-Breijo, Borja ; Ortega, Miguel A....
International Journal of Molecular Sciences.  21 (2020)  23 - p. 9101 , 2020
Link: https://doi.org/10.3390/..
 
?
13

Blood Lymphocyte Subsets for Early Identification of Non-Re..:

Rodríguez-Martín, Eulalia ; Nieto-Gañán, Israel ; Hernández-Breijo, Borja...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
14

Infliximab concentrations in two non-switching cohorts of p..:

Martínez-Feito, Ana ; Bravo-Gallego, Luz Yadira ; Hernández-Breijo, Borja...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
15

Functional rare variants influence the clinical response to..:

Chaparro, María ; Aterido, Adrià ; Guerra, Iván...
Therapeutic Advances in Gastroenterology.  12 (2019)  - p. 175628481986784 , 2019
Link: https://doi.org/10.1177/..
 
1-15